Skip to main content
logo
Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
25.31
-0.34 (-1.33%)
Nov 6, 2026, 4:00 PM EST - Market closed

Neurogene Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
506319340249--
Market Cap Growth
28.02%-6.03%36.64%---
Enterprise Value
28964214452--
Last Close Price
25.3120.6022.8619.38--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---18.20--
PS Ratio
--367.11---
PB Ratio
1.851.211.091.34--
P/TBV Ratio
2.331.211.091.34--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--231.03---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.040.040.040.080.050.06
Net Debt / Equity Ratio
-1.00-0.98-0.97-0.98-0.78-0.76
Net Debt / EBITDA Ratio
1.842.593.783.481.451.32
Net Debt / FCF Ratio
2.483.314.203.521.411.01
Asset Turnover
--0.00---
Quick Ratio
10.5016.4220.658.6112.486.57
Current Ratio
10.6516.5620.848.7212.746.81
Return on Equity (ROE)
-45.31%-31.41%-30.28%-25.52%-59.77%-
Return on Assets (ROA)
-27.98%-20.66%-18.47%-20.94%-33.52%-
Return on Capital Employed (ROCE)
-54.40%-37.90%-25.70%-27.80%-55.10%-55.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-19.93%-28.32%-22.13%-14.61%--
FCF Yield
-17.32%-24.56%-21.03%-20.82%--
Buyback Yield / Dilution
-12.28%-21.40%-277.22%-1080.37%90.26%-
SEC Filings: 10-K · 10-Q